信隆健康：10月23日召开董事会会议

Group 1 - The core point of the article is that Xinlong Health (SZ 002105) held its first board meeting of the eighth session on October 23, 2025, where it reviewed the third quarter report for 2025 [1] - For the first half of 2025, Xinlong Health's revenue composition was as follows: bicycle accessories accounted for 67.29%, sports and rehabilitation equipment accounted for 30.59%, and other businesses accounted for 2.12% [1] - As of the time of reporting, Xinlong Health had a market capitalization of 2.6 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing deals this year, indicating a hot secondary market in biomedicine [1] - There is a discussion on why fundraising in the primary market is facing challenges despite the active secondary market, featuring insights from Lu Gang, a partner at Chuangdong Investment [1]